1 Product identity
Ingredient risk
1 ingredient to use with caution

Libitrol

BrandDirect Alternatives→Botanical with Nutrients Tablet or Pill 18 ingredients 1 caution DSLD #31009
Net contents: 60 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2014-03-25
2 Ingredients (18)
IngredientGroupSafety
Libitrol BlendProprietary Blend (Combination)—
L-Arginine HydrochlorideArginine—
YohimbeYohimbe—
Da ZaoJujube —
Panax ginseng root extractOriental Ginseng—
saw palmettoSaw PalmettoGenerally Safe
DamianaDamianaConditionally Safe
L-AlanineAlanine—
ginkgo bilobaGinkgo —
L-Glutamic AcidGlutamic Acid—
L-LysineLysine—
Dicalcium PhosphateCalciumConditionally Safe
Microcrystalline CelluloseCellulose—
Croscarmellose SodiumCroscarmellose Sodium—
Stearic AcidStearic Acid—
SilicaSiliconGenerally Safe
Magnesium StearateMagnesiumUse with Caution
Pharmaceutical GlazeCoating—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Chloride — Limited Evidence
⚠ Co-ingested with sodium
Panax Ginseng — Limited Evidence
⚠ Insomnia
⚠ Estrogenic effects
Saw Palmetto — Generally Safe
⚠ Anti-androgenic
⚠ May affect PSA
Damiana — Conditionally Safe
⚠ May lower blood glucose
⚠ Hallucinations at very high doses
Ginkgo Biloba — Limited Evidence
⚠ BLEEDING RISK
⚠ Seizures (ginkgotoxin)
L-Lysine — Limited Evidence
⚠ GI discomfort at high doses
⚠ May increase calcium absorption
Calcium — Conditionally Safe
⚠ Cardiovascular risk debated >1,000 mg/day
⚠ Kidney stones
Sodium — Limited Evidence
⚠ Hypertension
⚠ Fluid retention
Silicon — Generally Safe
⚠ Very low toxicity
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
GLA — Limited Evidence
⚠ May lower seizure threshold
⚠ Borage oil: hepatotoxic unless PA-free
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID31009
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2014-03-25
6 More from Direct Alternatives
View Direct Alternatives Safety Scorecard → 1 products
7 Cite this page
Vancouver
Pkhakadze G. Libitrol — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 25]. Available from: https://supplement.ge/products/libitrol-31009/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG